mianserin has been researched along with Genetic Predisposition in 3 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HS | 3 |
| Won, ES | 1 |
| Lee, HY | 3 |
| Ham, BJ | 2 |
| Kim, YG | 1 |
| Lee, MS | 3 |
| Won, E | 1 |
| Kang, RH | 1 |
| Paik, JW | 1 |
| Jeong, YJ | 1 |
| Han, SW | 1 |
3 other studies available for mianserin and Genetic Predisposition
| Article | Year |
|---|---|
Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrestins; beta-Arrestin 1; beta-Arrestins; Depressiv | 2015 |
Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Case-Control Studies; Citalopram; Cortico | 2015 |
Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Depressive Disorder, Major; Female; Genetic Predisposition to D | 2009 |